Discover the Precision Oncology portfolio of genomic tests from Exact Sciences, which delivers actionable insights for breast, prostate, colon, and other solid tumors.
A Physician Assistant's Perspective: Treatment Planning in NRG1+ NSCLC and Pancreatic Cancer DNA vs RNA Sequencing in NSCLC and Pancreatic Cancer Current Approaches and Treatment Challenges in NRG1+ NSCLC and Pancreatic CancerVideo Interviews Dr Wang on Ziftomenib Plus Intensive Induction in Newly Di...
Effect of real-time data-driven physician engagement on appropriate precision oncology testing.doi:10.1200/JCO.2024.42.16_suppl.111687632211168#Background:Precision medicine is a paradigm shift in healthcare: 24% of all FDA approvals are precision medicines, with 67% of new approvals relying ...
2b). This page displays select clinical and genomic features of each trial match and provides a link to email a patient’s physician to help determine their eligibility and interest in a PM trial. As patient eligibility is reviewed, clinicians can place patients in “bins” according to their...
While individual precision oncology studies require fixed versions of alteration–action knowledge bases, the rapidly expanding scope of literature on which these databases originate requires constant updating, which makes prospective assessment of precision oncology programs difficult. This challenge was evident...
I was referred to my first team of doctors by my primary care physician. I had a great vibe with my first breast surgeon – she was smart and kind, and I trusted her implicitly. However, I did not have a great connection with the team of oncologists. They were not there at the ...
Precision medicine empowers a physician to treat cardiac diseases individualistically, based on the patient’s unique genetic, metabolic, proteomic, or symptomatic profile. The strength of precision medicine lies in the synthesis and analysis of “data” that is rapidly changing from standard clinical...
Three-dimensional printed models could also facilitate patient–physician communication. VR and AR help in seeing the 3D image of the patient’s anatomy by providing a 3D immersive view, with the possibility of interacting closely with it. These three technologies are becoming increasingly popular, ...
40. LncRNAs are highly suited as oncology targets due to their superior tissue- and cancer-specific expression compared to protein-coding genes41,42,43. They have the potential to serve as clinically relevant biomarkers to improve diagnosis, prediction of recurrence, therapeutic targeting, treatment ...
Which best describes your role? Choose the option that best describes your current role. Health care provider Delegate NEXT Go back to login page Need help? Contact us Oncotype DX, Oncotype DX Breast Recurrence Score, Breast Recurrence Score, Recurrence Score, Oncotype DX DCIS Score, DCIS ...